WealthBridge Investment Counsel Inc. Sells 225 Shares of Danaher Co. (NYSE:DHR)

WealthBridge Investment Counsel Inc. lessened its stake in Danaher Co. (NYSE:DHR) by 1.5% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 15,235 shares of the conglomerate’s stock after selling 225 shares during the period. WealthBridge Investment Counsel Inc.’s holdings in Danaher were worth $3,123,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Blue Zone Wealth Advisors LLC raised its position in Danaher by 14.6% during the 1st quarter. Blue Zone Wealth Advisors LLC now owns 19,221 shares of the conglomerate’s stock valued at $3,940,000 after purchasing an additional 2,443 shares during the last quarter. Independence Bank of Kentucky raised its position in Danaher by 9.7% during the 1st quarter. Independence Bank of Kentucky now owns 6,866 shares of the conglomerate’s stock valued at $1,408,000 after purchasing an additional 605 shares during the last quarter. Horizon Wealth Management LLC purchased a new position in shares of Danaher during the 1st quarter worth approximately $407,000. Chemistry Wealth Management LLC grew its holdings in shares of Danaher by 25.6% during the 1st quarter. Chemistry Wealth Management LLC now owns 6,201 shares of the conglomerate’s stock worth $1,271,000 after acquiring an additional 1,262 shares during the period. Finally, Atwater Malick LLC grew its holdings in shares of Danaher by 6.3% during the 1st quarter. Atwater Malick LLC now owns 1,597 shares of the conglomerate’s stock worth $327,000 after acquiring an additional 95 shares during the period. Institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

DHR has been the topic of a number of research analyst reports. Citigroup reiterated a “buy” rating on shares of Danaher in a report on Monday, April 7th. JPMorgan Chase & Co. dropped their price target on Danaher from $280.00 to $260.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 22nd. Jefferies Financial Group lowered their price objective on Danaher from $260.00 to $230.00 and set a “buy” rating on the stock in a research report on Tuesday, April 22nd. Royal Bank of Canada reissued an “outperform” rating and set a $250.00 price target on shares of Danaher in a report on Wednesday, April 23rd. Finally, HSBC lowered their price target on Danaher from $270.00 to $240.00 in a report on Friday, April 25th. Four equities research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $263.24.

Insider Transactions at Danaher

In related news, Chairman Steven M. Rales sold 1,250,000 shares of Danaher stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $196.74, for a total value of $245,925,000.00. Following the completion of the transaction, the chairman now owns 3,105,808 shares in the company, valued at approximately $611,036,665.92. This trade represents a 28.70% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Christopher Paul Riley sold 15,805 shares of Danaher stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the transaction, the executive vice president now owns 15,179 shares of the company’s stock, valued at approximately $3,005,442. This represents a 51.01% decrease in their position. The disclosure for this sale can be found here. Insiders own 11.10% of the company’s stock.

Danaher Price Performance

NYSE:DHR opened at $196.13 on Friday. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The business’s 50-day simple moving average is $191.34 and its two-hundred day simple moving average is $212.34. The stock has a market cap of $140.36 billion, a PE ratio of 37.15, a P/E/G ratio of 2.66 and a beta of 0.80. Danaher Co. has a 52 week low of $171.00 and a 52 week high of $281.70.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, beating analysts’ consensus estimates of $1.62 by $0.26. Danaher had a return on equity of 10.82% and a net margin of 16.33%. The business had revenue of $5.74 billion for the quarter, compared to analysts’ expectations of $5.58 billion. As a group, analysts forecast that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be issued a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.65%. Danaher’s dividend payout ratio (DPR) is 24.85%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.